[Treatment of chronic hepatitis B].
D000212:Acyclovir / Q000627:therapeutic use; D001500:BCG Vaccine / Q000627:therapeutic use; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D006509:Hepatitis B / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D006510:Hepatitis B Antibodies / Q000008:administration & dosage; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D007978:Levamisole / Q000627:therapeutic use; D014165:Transfer Factor / Q000627:therapeutic use; D014740:Vidarabine / Q000627:therapeutic use; D001084:Vidarabine Phosphate / Q000627:therapeutic use
D001500:BCG Vaccine; D006510:Hepatitis B Antibodies; D014165:Transfer Factor; D001084:Vidarabine Phosphate; D007978:Levamisole; D007372:Interferons; D014740:Vidarabine; D000212:Acyclovir
Tratamiento de la hepatitis crónica por virus B.